Skip to main content

Table 1 Interpretation of markers used in hepatitis B screening [2, 53]

From: A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries

Marker (abbreviation)

Description

Hepatitis B surface antigen (HBsAg)

marker of acute or chronic hepatitis B infection

Hepatitis B surface antibody (anti-HBs)

a high level indicates previous infection or response to vaccination and current immunity (generally ≥10 IU/L considered ‘protected’)

Hepatitis B e antigen (HBeAg)

presence indicates high infectivity

Total hepatitis B core antibody (anti-HBc)

indicates resolved infection if positive for this and hepatitis B surface antibody, but negative for HBsAg; will be positive along with HBsAg in acute or chronic hepatitis B infection; if positive but negative for HBsAg and hepatitis B surface antibody, usually indicates distant resolved hepatitis B infection